Ikarian Capital, LLC - Mar 31, 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value (AVTX)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol
AVTX
Shares outstanding
11.9M shares
Disclosed Ownership
1.19M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 05:33 PM
Date of event
Mar 31, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 9.99% 1.19M 0 1.19M /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 9.99% 1.19M 0 1.19M /s/ Neil Shahrestani Neil Shahrestani, Sole Manager